Trial Condition(s):
Multiple Sclerosis
"BRIGHT" (Betaferon® vs. Rebif® Investigating Higher Tolerability) Observational Study to assess Injection Site Pain in Multiple Sclerosis patients
Bayer Identifier:
308100
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
Please see attached Study Results Summary below.
Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available
Trial Summary
Enrollment Goal
454
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
Betaseron (Interferon beta-1b, BAY86-5046)
Accepts Healthy Volunteers
N/A
Where to Participate
Locations
| Locations |
|---|
Trial Design
"BRIGHT"(Betaferon® vs. Rebif® Investigating Higher Tolerability) Observational Study to assess Injection Site Pain in Multiple Sclerosis patients treated with Betaferon® vs. Rebif®
Trial Type:
Observational
Intervention Type:
N/A
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
N/A
Primary Outcome
- Timeframe:
Secondary Outcome
- Timeframe:
Additional Information
Copyright © Bayer
Powered by
